Pricing Log in Create free account
Friday 6 November 2026 Export NEOG’s income statement to Excel — free account

Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.88 0.20 +1.71%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Neogen Corporation (NEOG) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Neogen Corporation (NEOG) trades at a EV/Sales of 3.6×. Over the past ten years it has ranged from 1.5× (October 2022) to 11.8× (September 2018); the current reading is higher than 16% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 2.9× 32.01%
FY2025 2.2× (42.10%)
FY2024 3.9× (19.57%)
FY2023 4.8× 2.44%
FY2022 4.7× (51.01%)
FY2021 9.6× 16.47%
FY2020 8.2× 27.97%
FY2019 6.4× (30.60%)
FY2018 9.2× 46.84%
FY2017 6.3× 16.27%

Quarterly newest first

Period EV/Sales Change
Aug 2026 3.6× 20.52%
May 2026 2.9× (16.62%)
Feb 2026 3.5× 59.41%
Nov 2025 2.2× 3.72%
43 more quarters

Against its own ten years

Low 1.5× High 11.8×
Ten-year median 6.4×
Current reading's percentile 17

EV/Sales against peers

Company EV/Sales
INSP Inspire Medical Systems, Inc. compare 1.8×
ITGR Integer Holdings Corporation compare 3.0×
NEOG Neogen Corporation 3.6×
UFPT UFP Technologies, Inc. compare 3.7×
TMDX TransMedics Group, Inc. compare 3.8×
ESTA Establishment Labs Holdings Inc. compare 8.7×
AXGN AxoGen, Inc. compare 8.8×
BFLY Butterfly Network, Inc. compare 12.5×
ALMR Alamar Biosciences, Inc. compare 15.6×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on NEOG